This disclosure relates to capturing and isolating target materials of a suspension.
Suspensions often include particles of interests that are difficult to extract and isolate for analysis because the particles occur with such low frequency. For example, blood is a suspension of various particles that is routinely examined for the presence of abnormal organisms or cells, such as circulating tumor cells (“CTCs”), ova, parasites, microorganisms, and inflammatory cells. CTCs are of particular interest because CTCs are cancer cells that have detached from a primary tumor, circulate in the bloodstream, and may be regarded as seeds for subsequent growth of additional tumors (i.e., metastasis) in different tissues. As a result, detecting, enumerating, and characterizing CTCs may provide valuable information in monitoring and treating cancer patients. Although detecting CTCs may help clinicians and cancer researchers predict a patient's chances of survival and/or monitor a patient's response to cancer therapy, CTC numbers are typically very small and are not easily detected. In particular, typical CTCs are found in frequencies on the order of 1-10 CTCs per milliliter sample of whole blood obtained from patients with a metastatic disease. By contrast, a single milliliter sample of whole blood typically contains a few million white blood cells and a billion red blood cells.
However, isolating and identifying a particular type of low frequency particle of interest can be difficult when the suspension includes other particles having similar shape, size, and density. For example, isolating and identifying CTCs in a blood sample can be difficult because a typical blood sample includes other cells with similar shape, size, and density as the CTCs, such as white blood cells. Practitioners, researchers, and those working with suspensions continue to seek systems and methods for isolating particles of interest from other particles that are not of interest but have a similar shape, size, and density.
This disclosure is directed to methods for isolating target materials from non-target materials of a suspension that have a similar density to that of the target material. A suspension suspected of containing a target material is added to a tube. A solution containing molecules that interact specifically with the non-target materials to change the density of the non-target materials in also added to the tube. A float is also added to the tube, and the tube, float, and suspension are centrifuged together, causing the various materials suspended in the suspension to separate into different layers along the axial length of the tube according to their specific gravities. The float has a specific gravity that positions the float at approximately the same level as a layer containing the target material when the tube, float and suspension are centrifuged. During centrifugation, the non-target material/molecules complexes are drawn either below the float or above float, leaving the target material between the outer surface of the float and the inner surface of the tube.
A suspension is a fluid containing particles that are sufficiently large for sedimentation. A typical suspension may contain, in addition to a sought after target material, a wide variety of other materials. Examples of suspensions include paint, urine, anticoagulated whole blood, and other bodily fluids. A target material can be cells, organisms, or particles whose density equilibrates when the suspension is centrifuged. Examples of target materials found in suspensions obtained from living organisms include cancer cells, ova, inflammatory cells, viruses, parasites, and microorganisms, each of which has an associated specific gravity or density. When the suspension is added to a tube and float system and centrifuged, the various materials separate into different layers along the axial length of the tube according to their specific gravities. The float can be selected with a specific gravity to substantially match that of the target material. As a result, after centrifugation, the float is ideally positioned at approximately the same level as a layer containing the target material and expands the axial length of the layer containing the target material so that nearly the entire quantity of target material is positioned between the float outer surface and the inner surface of the tube. However, when the amount of target material is small and other non-target materials having a similar density to that of the target material also fill the region between the outer surface of the float and the inner surface of the tube, isolation and identification of the target material can be problematic. Methods of this disclosure are directed to preventing the non-target materials with a similar specific gravity similar to that of the target material from accumulating in the region between the float outer surface and the inner surface of the tube during centrifugation, making isolation and identification of the target material substantially less problematic.
The detailed description is organized into two subsections as follows: Various tube and float systems for isolating and separating target materials from other materials in a suspension are described below in a first subsection. Methods for separating the non-target materials from target materials using tube and float systems are described in a second subsection.
In other embodiments, the main body of the float 104 can be configured with a variety of different support structures for separating target materials, supporting the tube wall, or directing the suspension fluid around the float during centrifugation.
In
In
In alternative embodiments, a float can include a pressure release system to alleviate pressure that builds up in the fluid trapped below the float during centrifugation. The pressure release system prevents the material or particles trapped in the fluid below the float from being forced into an annular gap between the outer surface of the tube and the inner wall of the tube, which contains the target material. This pressure may cause fluid to be forced into the annular gap, thus making detection of the contents of the target material more difficult. Alternatively, the collapse of the side wall of the tube during deceleration may produce excessive or disruptive fluid flow through the annular gap between the main body of the float and the inner wall of the tube 102. The pressure release system can be bore holes that run the axial length of the float and allow for any excessive fluid flow or any resultant pressure in the dense fractions trapped below the float to be relieved. The excess fluid flows into the bore holes, thus preventing degradation of the trapped target material.
Embodiments of the present invention include other types of geometric shapes for float end caps.
A float can be composed of a variety of different materials including, but are not limited to, rigid organic or inorganic materials, and rigid plastic materials, such as polyoxymethylene (“Delrin®”), polystyrene, acrylonitrile butadiene styrene (“ABS”) copolymers, aromatic polycarbonates, aromatic polyesters, carboxymethylcellulose, ethyl cellulose, ethylene vinyl acetate copolymers, nylon, polyacetals, polyacetates, polyacrylonitrile and other nitrile resins, polyacrylonitrile-vinyl chloride copolymer, polyamides, aromatic polyamides (“aramids”), polyamide-imide, polyarylates, polyarylene oxides, polyarylene sulfides, polyarylsulfones, polybenzimidazole, polybutylene terephthalate, polycarbonates, polyester, polyester imides, polyether sulfones, polyetherimides, polyetherketones, polyetheretherketones, polyethylene terephthalate, polyimides, polymethacrylate, polyolefins (e.g., polyethylene, polypropylene), polyallomers, polyoxadiazole, polyparaxylene, polyphenylene oxides (PPO), modified PPOs, polystyrene, polysulfone, fluorine containing polymer such as polytetrafluoroethylene, polyurethane, polyvinyl acetate, polyvinyl alcohol, polyvinyl halides such as polyvinyl chloride, polyvinyl chloride-vinyl acetate copolymer, polyvinyl pyrrolidone, polyvinylidene chloride, specialty polymers, polystyrene, polycarbonate, polypropylene, acrylonitrite butadiene-styrene copolymer and others.
For the sake of convenience, methods for isolating a target material in a suspension are described with reference to an example suspension and example target material. In this example, the target materials are CTCs, the non-target materials are white blood cells (“WBCs”), and the suspension is anticoagulated whole blood. Note however that methods of the present invention are not intended to be so limited in their scope of application. The methods described below can, in practice, be used to isolate any kind of target material from a non-target material in nearly any kind of suspension and are not limited to isolating CTCs from WBCs of a whole blood sample.
Certain methods for separating a non-target material from a target material include introducing a solution containing ligands with attached weights to the suspension. The ligands are selected to bind specifically to non-target material particles and not to bind to target material particles. A ligand can be a molecule that binds to a particular binding site of a non-target particle. A weight can be a molecule that effectively changes in the specific gravity of the non-target particle.
A solution containing the ligand/weight complex is added to the suspension and the ligand/weight complexes are allowed to bind to the non-target particles.
In certain embodiments, the weights can be selected to increase the mass of the complex 606 so that when the tube and float system is centrifuged, the complexes 606 are drawn below the float 104. For example, the weights 601 can be metal-based compounds, metal complexes, or quantum dots.
In certain embodiments, the weights can be selected to decrease the density of the complex 606 so that when the tube and float system is centrifuged, the complexes 606 are drawn above the float 104. For example, the weights 601 can be lipids or sugars.
In certain embodiments, the weight 601 can be a magnetically permeable particle and the compound 600 is a magnetically permeable compound. For example, the weight 601 can be a paramagnetic particle, ferromagnetic particle, or an ion that can be used to draw the complex 606 below or above the float 104 in accordance with an applied magnetic field.
Note that the magnetic field 1006 can be applied prior to centrifugation or during centrifugation. For example, the tube and float system 100 can be placed between the magnets 1002 and 1004 for a period of time prior to centrifugation, or the magnet 1002 can be attached to the cap 112, or embedded within the cap 112, and the magnet 1004 can be attached to the closed end 108 or placed in the bottom of a centrifuge chamber prior to placement of the tube and float system 100, enabling the system 100 and magnets 1002 and 1004 to be centrifuged together. Alternatively, the electromagnetic system 1008 can be applied for a period of time prior to centrifugation, or the system 100 with the electromagnetic system 1008 attached can be centrifuged together.
In still other embodiments, the non-target particles can be exposed to a molecule that when absorbed lowers the density of the non-target particles. The molecule is referred to as “buoyant molecule.”
A solution containing the buoyant molecules is added to the suspension and the non-target particles are allowed a period of time to absorb the buoyant molecules.
When centrifugation begins low density particles are drawn upward while higher density particles are drawn downward.
The foregoing description, for purposes of explanation, used specific nomenclature to provide a thorough understanding of the disclosure. However, it will be apparent to one skilled in the art that the specific details are not required in order to practice the systems and methods described herein. The foregoing descriptions of specific embodiments are presented for purposes of illustration and description. They are not intended to be exhaustive of or to limit this disclosure to the precise forms described. Obviously, many modifications and variations are possible in view of the above teachings. The embodiments are shown and described in order to best explain the principles of this disclosure and practical applications, to thereby enable others skilled in the art to best utilize this disclosure and various embodiments with various modifications as are suited to the particular use contemplated. It is intended that the scope of this disclosure be defined by the following claims and their equivalents:
This application claims the benefit of Provisional Application No. 61/254,290, filed Oct. 23, 2009.
Number | Date | Country | |
---|---|---|---|
61254290 | Oct 2009 | US |